APA (7th ed.) Citation

Koumprentziotis, I., Rompoti, N., Stefanaki, I., Vavouli, C., Papoutsaki, M., Politou, M., . . . Nicolaidou, E. (2025). Switching within the class of IL‐17 inhibitors for the treatment of plaque psoriasis: A real‐world retrospective study. Australasian journal of dermatology, 66(2), 101-104. https://doi.org/10.1111/ajd.14396

Chicago Style (17th ed.) Citation

Koumprentziotis, Ioannis‐Alexios, Natalia Rompoti, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Maria Politou, Alexander Stratigos, and Electra Nicolaidou. "Switching Within the Class of IL‐17 Inhibitors for the Treatment of Plaque Psoriasis: A Real‐world Retrospective Study." Australasian Journal of Dermatology 66, no. 2 (2025): 101-104. https://doi.org/10.1111/ajd.14396.

MLA (9th ed.) Citation

Koumprentziotis, Ioannis‐Alexios, et al. "Switching Within the Class of IL‐17 Inhibitors for the Treatment of Plaque Psoriasis: A Real‐world Retrospective Study." Australasian Journal of Dermatology, vol. 66, no. 2, 2025, pp. 101-104, https://doi.org/10.1111/ajd.14396.